A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy
Clinical trial NCT03813784 · COMPLETED
Trial details
- NCT number
- NCT03813784
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-07
- Primary completion
- 2023-06-07
- Enrollment
- 885
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.